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Summary
Novel experimental methods, including a modified single fiber in
vitro motility assay, X-ray diffraction experiments, and mass
spectrometry analyses, have been performed to unravel the
molecular events underlying the aging-related impairment in
human skeletal muscle function at the motor protein level. The
effects of old age on the function of specific myosin isoforms
extracted from single human muscle fiber segments, demon-
strated a significant slowing of motility speed (P < 0.001) in old
age in both type I and IIa myosin heavy chain (MyHC) isoforms.
The force-generating capacity of the type I and IIa MyHC isoforms
was, on the other hand, not affected by old age. Similar effects
were also observed when the myosin molecules extracted from
muscle fibers were exposed to oxidative stress. X-ray diffraction
experiments did not show any myofilament lattice spacing
changes, but unraveled a more disordered filament organization
in old age as shown by the greater widths of the 1, 0 equatorial
reflections. Mass spectrometry (MS) analyses revealed eight age-
specific myosin post-translational modifications (PTMs), in which
two were located in the motor domain (carbonylation of Pro79
and Asn81) and six in the tail region (carbonylation of Asp900,
Asp904, and Arg908; methylation of Glu1166; deamidation of
Gln1164 and Asn1168). However, PTMs in the motor domain were
only observed in the IIx MyHC isoform, suggesting PTMs in the
rod region contributed to the observed disordering of myosin
filaments and the slowing of motility speed. Hence, interventions
that would specifically target these PTMs are warranted to
reverse myosin dysfunction in old age.
Key words: aging; function; myosin; post-translational
modification; skeletal muscle.
Introduction
Falls are a major cause of morbidity and mortality in the growing
population of elderly citizens, constituting the leading reason of
unintentional injury deaths in individuals over the age of 79. The source
of falls and fall-related injuries in old age are complex and involve
multiple risk factors. The aging-related impairments in somatosensa-
tion, vision, and vestibular function have negative effects on maintain-
ing postural balance. However, the difficulty in recovering from a
threatening fall, which is impaired in old age, is not related to an
impairment of the sensory process or to the motor planning that leads
to the initiation of muscle contraction (Schultz et al., 1997). Events
after depolarization of skeletal muscle play a major role in the inability
to correct the fall, that is, in force-generating capacity and contractile
speed (Schultz et al., 1997). In support of this, the decline in mobility
and lower extremity disability has been reported most influential in
predicting falls in the elderly (Whipple et al., 1987; Blake et al., 1988;
Robbins et al., 1989). Further, aging affects specific types of muscles,
motor units, and muscle cells differently, and a detailed understanding
of sarcopenia requires studies of muscle fibers of both the fast- and
slow-twitch type (Larsson & Ansved, 1995). Hence, understanding the
aging muscle, more specifically the loss of speed and force in old age,
appears primordial in deciphering potential ‘preventative’ or ‘thera-
peutic’ approaches.
Muscle contraction requires the proper functioning of the sarcomere,
and thus, one of its major structural components, the motor protein
myosin. Myosin molecules have a slow turnover rate, that is, 1–2% per
day (Smith & Rennie, 1996) which makes them preferential targets for
different types of post-translational modifications (PTMs) by reactive
oxygen or nitrogen species. We have previously shown that there is
evidence to indicate that PTMs may affect enzymatic activity, stability,
and digestibility of myosin during aging (Larsson & Ansved, 1995; Hook
et al., 1999). A few studies have tried to quantify PTMs in myosin
molecules by focusing on a few selected markers, including carbonyla-
tion, nitration, formation of HNE (4-hydroxy-2-nonenal) adducts, and
glycation (Syrovy & Hodny, 1992; Watanabe et al., 1992; Oh-Ishi et al.,
2003). Unfortunately, there is no consensus regarding aging-related
changes in the levels of these markers or their precise localization.
Indeed, oxidation of one or two reactive myosin cysteines (Cys707 and
Cys696) could be crucial and may well trigger motor dysfunction
(Crowder & Cooke, 1984). Similarly, glycation of some myosin lysine-rich
regions that are important for actin binding and ATPase activity may play
a primordial role (Ramamurthy et al., 2001; Ramamurthy & Larsson,
2013).
In this study, we aimed to determine the nature and location of
PTM sites using mass spectrometry in parallel with assessment of the
catalytic and force-generating capacity of specific myosin isoforms
using a modified single fiber in vitro motility assay and measure
conformational changes during single muscle fiber contraction using
small-angle X-ray scattering. We initially hypothesized that aging-
specific carbonylations, nitrations, and/or glycations in the myosin
motor domain would compromise the myosin head binding to actin
filaments subsequently resulting in a decreased speed of contraction
and force production.
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Aging effects on the function of myosin isoforms
All in vitro motility measurements have been restricted to muscle fibers
expressing the type I and type IIa MyHC isoform and fulfilling the criteria
for acceptance, due to the paucity of muscle fibers expressing the IIx
MyHC isoform in both young and old subjects. Results from in vitro
motility measurements in fibers expressing the same MyHC isoform have
been pooled as there was no difference between individuals within the
young and the old age groups. A total of nine and ten fibers from
the young subjects, 11 and 15 fibers from the old subjects expressing the
type I and IIa MyHC isoforms, respectively, were included in the analyses.
Single fibers were obtained from three young and five old subjects.
Regarding the evaluation of myosin under the oxidative stress in vitro, a
total of seven fibers were collected from one additional young male
subject and myosin function was compared between one half exposed
to oxidative stress and the other half of the fiber serving as control.
The motility speed was highly dependent on MyHC isoform as proven
by the absence of overlap between data from type I and IIa MyHC
isoforms. This strong dependence on MyHC isoform expression was
present in both age groups (Fig. 1A). However, an aging-related slowing
of motility speed was observed in both type I and IIa MyHC assays, that
is, motility speed declined from 0.62  0.09 lm s1 to
0.47  0.06 lm s1 in type I MyHC (P < 0.001) and from
1.27  0.17 lm s1 to 1.02  0.13 lm s1 in type IIa MyHC
(P < 0.001) assays (Fig. 1A).
The force index measured both as the slope and x-axis intercept
showed a large variability within each MyHC preparation and demon-
strated a significant overlap between type I and IIa MyHC isoforms, but
both the force indexslope (P < 0.05) and force indexintercept (P < 0.01)
showed a higher force index in type IIa than type I; however, there was
no significant aging-related change in the force indices (Fig. 1B,C). In the
type I MyHC, force indexslope was 183  25 vs. 170  21 and force
indexintercept was 0.39  0.05 vs. 0.46  0.06 in young and old
subjects, respectively. In the type IIa MyHC, force indexslope was
154  27 vs. 146  28 and force indexintercept was 0.52  0.11
vs. 0.49  0.09 in young and old subjects, respectively.
The motility speed of myosin molecules extracted from hydrogen
peroxide treated fibers was significantly decreased (P < 0.05) from 1.04
to 0.84 lm s1 (Fig. 1D). Similar to the comparisons between young
and old subjects, both the force indexslope (P = 0.536) and force
indexintercept (P = 0.256) were not significantly different, that is, force
indexslope were 155  40 vs. 138  46 and force indexintercept were




Fig. 1 Myosin function The distribution of motility speed (A), force indexslope (B), and force indexintercept (C) of MyHC isoforms (type I and IIa) in young and old human
muscle. The motility speed of the two halves of seven different single fibers (the oxidized and the control) (D).
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Myosin molecules are disordered during contraction in old
age
The muscle biopsy specimens from five young and seven old subjects and
more than 1000 membrane-permeabilized fibers were isolated and
mounted for small-angle X-ray experiments. The intensities of one
myosin meridional reflection (first MM) and of two actin layer lines (sixth
and seventh ALLs) were evaluated in the resting state (pCa 9.0) and
upon maximal activation, at saturating Ca2+ level (pCa 4.5). These
intensities were all enhanced at pCa 4.5, but the intensities were less
pronounced in the old individuals (Table 1, Fig. 2). To verify that the
phenomenon was not due to a compromised filament spacing, the 1, 0
equatorial reflections were evaluated and converted to d1, 0 lattice
spacing’s, using Bragg’s Law (Colson et al., 2007). The d1, 0 lattice
spacings were not affected by subject age, but the greater widths of the
1, 0 equatorial reflections (estimated via D1, 0) suggest a more
disordered arrangement in elderly individuals (Table 1).
Aging-specific post-translational modifications of different
myosin isoforms
A total of five young and nine old human samples from the vastus
lateralis muscle were run on 6% SDS-PAGE gel for MyHC isoforms
separations. Type I, IIa, and IIx MyHC isoforms gel bands were excised
and screened for acetylation, carbonylation, deamidation, glucosylation,
methylation, nitration, ubiquitination, and phosphorylation. Eight aging-
specific PTMs were identified. Two PTMs, that is, carbonylation of Pro79/
Asn81, were observed in the Src-homology domain 3 (SH3) of the
myosin motor domain (Fig. 3A). However, these PTMs were only
observed in the type IIx MyHC isoforms. The other six PTMs, that is,
carbonylation of Asp900/Asp904/Arg908, methylation of Glu1166, and
deamidation of Gln1164/Asn1168 were all in the rod domain of the
myosin molecule and present in all three MyHC isoforms (Fig. 3B).
Discussion
The results from this study confirmed and extended our previous studies:
(i) The significant difference between different myosin isoforms in speed
and force-generating capacity was confirmed at the motor protein level
(Hook et al., 1999; Hook & Larsson, 2000; Hook et al., 2001; Li et al.,
2006; Li & Larsson, 2010). (ii) An aging-related slowing of motility speed
was observed in both type I and IIa MyHC assays, but the force-
generating capacity was unaffected by age, irrespective of MyHC
isoform. Similar changes in myosin function were observed in response
to in vitro oxidative stress of myosin from young individuals. (iii) A myosin
molecule arrangement disorder was observed according to X-ray
diffraction analyses in old age. (iv) Aging-specific myosin modifications
were observed in the rod region of all MyHC isoforms expressed in
human adult limb muscles, that is, carbonylations, methylations, and
deamidations. It is proposed that these PTMs contribute to the
disordered myosin molecule organization and the slowing of motility
speed.
Post-translational modifications were observed at identical positions
in the myosin rod domain in all MyHC isoforms expressed in adult
human skeletal muscle as well as modifications in the S1 globular
domain in the IIx myosin isoform. Significantly less is known about the
mechanisms underlying the impaired muscle function induced by
modifications or mutations in the a-helical coiled-coil rod domain of the
myosin molecule than in the globular S1 head region containing the
catalytic domain and the actin-binding site. In this study, six-specific
aging-related PTMs (carbonylation, methylation, and deamidation) were
observed at identical positions in type I, IIa, and IIx MyHC isoforms. The
rod domain is essential for the packing of myosin molecules into
myosin filaments, for the binding of myosin-associated proteins, and
mutations in the rod region result in myopathic phenotypes (Ochala &
Larsson, 2012). Perturbations in the rod domain have been shown to
disturb sarcomeric uniformity and consequently influence the regulation
of muscle contraction (Cammarato et al., 2011). This is supported by
the disordered myosin orientation in old age according to X-ray
diffraction analyses. X-ray diffraction measurements in isolated mem-
brane permeable muscle fibers allow for the detection of structural
alterations of contractile proteins with high temporal and spatial
resolution (Koubassova & Tsaturyan, 2011). The 1st MM, corresponding
to the meridional reflection at 14.5 nm, gives an estimate of the
average orientation of the myosin cross-bridges with respect to the
thick filament backbone. The 6th and 7th ALLs stand for the actin layer
lines at 5.9 and 5.1 nm, respectively and reflect the conformational
changes occurring at the actin monomer level (Yagi & Matsubara,
1988). In the present study, as the first MM, sixth, and seventh ALLs
were less intensified upon activation in fibers from the older individuals,
we suggest that the mean orientation of the myosin heads bound to
actin monomers gets more disordered during contraction, inducing an
incomplete actin monomer activation and abnormal cross-bridge
formation. The d1, 0 lattice spacings were not different between
fibers from young and old individuals, but the widths of the 1, 0
equatorial reflections were significantly greater in fibers from the older
individuals. These data suggest that the filament spacing is not affected
during the aging process but the extent of actin–myosin lattice ordering
is altered, leading to a disrupted actomyosin interaction during muscle
contraction.
Oxidative stress-induced carbonylation is known to be a common
PTM in aging muscle, which was also verified in the myosin molecule in
this study. The increased oxidative stress in old age is related to: (i) an
increased electron flux and leakage from the mitochondrial electron
transport chain during contraction, (ii) high concentration of myoglobin,
known to confer greater sensitivity to free radical-induced damage
(Thompson, 2009), and (iii) accumulation of reactive oxygen and
nitrogen species from oxidative metabolism (Baraibar et al., 2013).
Two of the five PTMs in the rod region were carbonylations, and the
PTMs of Pro79 and Asn81 in the IIx MyHC SH3 domain were
carbonylations. Although the exact function of the SH3 domain is not
fully understood, the SH3 domain interacts directly with the N-terminal
extension of the myosin essential light chain. Essential light chains are
crucial for proper myosin functioning (Lowey et al., 1993; Lowey et al.,
2007), influencing ATPase kinetics (Hayashibara & Miyanishi, 1994) and
subsequently modulating maximum velocity of unloaded shortening
(Greaser et al., 1988; Lowey et al., 1993). Thus, the IIx MyHC-specific
Table 1 Different features of X-ray diffraction of muscle fiber in young and old
human muscle






Young relax 0.2831 1 0.2942 41.722 4.465
Young pCa 4.50 0.5891 1.1825 0.3524 39.583 5.059
Old relax 0.1676 1 0.2778 41.634 5.804
Old pCa 4.50 0.3845 1.1233 0.3085 39.544 6.291
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PTMs may have an additive effect on myosin function to the PTMs in the
rod region.
The hydrogen peroxide (H2O2) has been widely used to induce
oxidative stress in cellular systems in vitro, signified by increased carbonyl
content, an indicator of protein oxidation (Dargelos et al., 2010;
Baraibar et al., 2011). In the present study, after treatment with H2O2,
the motility speed of myosin decreased dramatically, which is in
agreement with results in aged subjects, implying the oxidative stress-
induced modifications compromise the myosin function.
An aging-related decline in maximum force normalized to cross-
sectional area (specific force) has been repeatedly documented in
membrane-permeabilized single muscle fibers from both humans and
rodents (Li & Larsson, 1996; Larsson et al., 1997; D’Antona et al., 2003;
Ochala et al., 2006). In this preparation, the excitation–contraction
coupling has been bypassed and the loss in specific force is exclusively
related to aging-related changes in contractile proteins, but does not
exclude additional aging-related changes in regulation of muscle
contraction upstream of the contractile protein level. Results from this
study at the motor protein level show that the decreased-specific force in
old age in membrane-permeabilized muscle fibers is not primarily related
to an aging-related change in myosin structure and function. This does
not, however, exclude that PTMs in other contractile proteins, such as
thin filament proteins, play an important role for the impaired force
generating capacity at the single muscle fiber level. In addition, the
altered stoichiometric relationship between myosin and actin contents
observed in old age in both rodent and human skeletal muscle with a
lower myosin to actin ratio in old age represents another potential
mechanism contributing to the aging-related decline in specific force
(Thompson et al., 2006; Cristea et al., 2010).
In conclusion, in the present study, we provide for the first time a
precise characterization of myosin structural and functional alterations in
old age from human muscle. Specific myosin PTMs appear in old age,
and they are located in both the myosin motor and rod domains and are
likely to contribute to myosin disorder and dysfunction. Such findings are
important for the design of potential future ‘preventative’ or ‘therapeu-
tic’ interventions aiming at reversing the muscle weakness in elderly
individuals. Successful profiling of aging-specific PTMs may also promote
the standardization of sarcopenia diagnosis.
Experimental procedures
Subjects
Skeletal muscle tissue from the tibialis anterior and vastus lateralis
muscles was collected from 12 young (20–35 years, the median age is
26 years) and 18 old (71–91 years, the median age is 76.5 years) male
and female healthy adults. All subjects included in in vitro motility assay
and mass spectrometry examination were males, and both male and
female subjects were included in the X-ray diffraction examinations. All
subjects were free of any musculoskeletal disease that may alter muscle
function. The study was approved by the ethical committee of the
Uppsala University and carried out according to the guidelines of the
Declaration of Helsinki. Written informed consent was obtained from all
subjects enrolled in the present study after they were fully informed of
the aim for the experiments and of the risks involved in the biopsy
procedure.
Muscle biopsies and fiber preparation
The muscle samples were obtained using the percutaneous conchotome
method from the vastus lateralis and tibialis anterior (TA). Then, samples
were separated into two portions. One piece was directly snap-frozen
and stored at 80 °C. The other portion was dissected into bundles of
approximately 50 fibers in relaxing solution at 4 °C and tied to glass
capillaries, stretched to about 110% of their resting slack length. The
bundles were chemically skinned by treatment for 24 h at 4 °C in a
relaxing solution containing 50% (vol/vol) glycerol and then stored at
20 °C. Within 1 week after skinning, the bundles were cryo-protected
by transferring, at 30-min intervals, to relaxing solutions containing
increasing concentrations of sucrose (0, 0.5, 1.0, 1.5, and 2.0 M) and
(A) (B) (C)
(D) (E) (F)
Fig. 2 X-ray diffraction patterns Low angle X-ray diffraction reflections. X-ray diffraction patterns of fibers from young (first row: A, B, and C) and older individuals
(second row: D, E, and F), in pre-activating (pCa 9.0, first column: A and D) and activating (pCa 4.5, second column: B and E) solutions. There are also differences in
intensity profiles (third column: C and F); red and blue colors indicate the enhanced and weakened areas, respectively, after addition of calcium. MM, myosin meridional;
ALL, actin layer line.
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then freezing in liquid propane chilled with liquid nitrogen. The frozen
bundles were stored at 80 °C. The day before an experiment, a bundle
was transferred to a 2.0 M sucrose solution for 30 min and then
incubated in solutions of decreasing sucrose concentration (1.5–0.5 M).
The bundle was then stored in skinning solution at 20 °C for up to
4 weeks.
Modified single-fiber myosin in vitro motility assay for speed
and force measurement
Unregulated actin was purified from rabbit skeletal muscle (Pardee &
Spudich, 1982) and fluorescently labeled with rhodamine-phalloidin
(Invitrogen, USA). The modified single-fiber myosin in vitro motility
system for speed and force measurement has been described in detail
elsewhere (Hook et al., 1999; Hook & Larsson, 2000; Li & Larsson,
2010). In brief, a short muscle fiber segment (1–2 mm) is placed on a
glass slide between two strips of grease, and a coverslip placed on top,
creating a flow cell of ~2 lL. Myosin is extracted from the fiber segment
through addition of a high-salt buffer (0.5 M KCl, 25 mM HEPES, 4 mM
MgCl2, 4 mM EGTA and the pH value was adjusted to 7.6 before adding
2 mM ATP and 1% b-mercaptoethanol). After 30 min incubation on ice,
a low-salt buffer (25 mM KCl, 25 mM HEPES, 4 mM MgCl2, 1 mM EGTA
and the pH value was adjusted to 7.6 before adding 1% b-mercapto-
ethanol) is applied, followed by BSA (1 mg mL1). Nonfunctional myosin
molecules were blocked with fragmentized F-actin, and rhodamine-
phalloidin labeled actin filaments were subsequently infused into the
flow cell, followed by motility buffer to initiate the movement (2 mM
ATP, 0.1 mg mL1 glucose oxidase, 23 lg mL1 catalase, 2.5 mg mL1
glucose, and 0.4% methyl cellulose in low-salt buffer). The pH of the
buffers was adjusted with KOH, and the final ionic strength of the
motility buffer was 71 mM. The flow cell was placed on the stage of an
inverted epifluorescence microscope (model IX 70; Olympus America
Inc., NY) and thermostatically controlled at 25 °C. Actin movements
were filmed with an image-intensified SIT camera (SIT 66; DAGE-MIT
Inc., USA) and recorded on videotape.
The unit concentration (0.1 lg mL1 in this study) of a-actinin
(A9776; Sigma-Aldrich, Sweden AB, Stockholm) dissolved in the low-salt
buffer was chosen as the lowest concentration that would reduce the
number of moving actin filaments. Multiples of this concentration were
added to the flow cell over a fourfold range in the a-actinin
concentration, that is, from 0.1 to 0.4 lg mL1. A specific area on the
glass slide was defined by a UV-marking pen (Chr Winther-S€orensen AB,
Kn€ared, Sweden) before creating the flow cell. After identifying an
organized moving filament, 3 lL a-actinin was applied to the flow cell,
(A)
(B)
Fig. 3 Myosin post-translational modifications (A) Ribbon diagram of the molecular motor protein myosin. Two aging-specific post-translational modifications (PTMs)
observed in the type IIx MyHC in old human muscle are highlighted in red (carbonylation of Pro79) and in beige (carbonylation of Asn81). (B) Post-translational aging-related
modifications in the rod region of all MyHC isoforms (types I, IIa and IIx). A schematic overview of the positions of the amino acids with a specific PTM: deaminations of
Gln1164 and Asn1168 and methylation of Glu1166. The positions of the carbonylations at Asp 900 (Blue) Asp904 (Green) and Arg908 (Red) in the coiled-coil structure of
the myosin rod are shown in the inset. The images were created with PyMol (http://www.pymol.org) using the atomic coordinates of Protein Data Bank entry 2FXM
(Blankenfeldt et al. 2006).
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incubated for 1 min, and followed by motility buffer. Moving filaments
within the defined area, with constant myosin concentration, were
recorded for 12 s to allow measurement of the number and speed of
actin filaments at the different a-actinin concentrations, that is, the
duration was long enough for reliable measurements, but short enough
to minimize the risk of photo-bleaching interference.
For speed analysis, from each single-fiber preparation, 20 actin
filaments that were moving at constant speed in an oriented motion
were selected. Recordings and analysis were only performed from
preparations in which > 90% of the filaments moved bi-directionally. A
filament was tracked from the center of mass, and the speed was
calculated from ten frames at an acquisition rate of five or one frame (s) per
second, depending on the fiber type, using an image analysis package
(IMAGE-PRO PLUS Version 6.0; Media Cybernetics, USA) (Hook & Larsson,
2000). The mean speed of the 20 filaments was calculated. Two force
indices were used. First, the slope (regression coefficient, force indexslope)
of the negative linear relationship between the relative fraction of moving
filaments and alpha-actinin concentration, that is, the number of moving
filaments normalized tomoving filaments prior to additionof alpha-actinin
vs. increasing alpha-actinin concentrations (the initial recording prior to
adding alpha-actinin was omitted from the regression analyses as it may
have a disproportional large impact on the regression line). Second, the x-
axis intercept value of the regression line was also used as a force index
(force indexintercept) (Li & Larsson, 2010).
Hydrogen peroxide-induced oxidative stress on single muscle
fiber
A 4- and 5-mm muscle fiber segment was dissected and placed in
relaxing solution at 4 °C, and then, it was cut into two segments with
equal length. One segment was incubated with 5 mM Hydrogen
Peroxide (H2O2, 34.01 g mol
1; Sigma-Aldrich, Sweden AB, Stockholm)
in relaxing solution for 5 min, while the other half was incubated in
relaxing solution for the same duration. Both segments were then
transferred to relaxing solution for 1 min prior to the in vitro motility
measurements (described above).
X-ray diffraction recordings and analyses
Two to 3 days prior to X-ray recordings, bundles were desucrosed,
transferred to a relaxing solution and fibers were dissected. Arrays of
approximately 30 fibers were set up (Iwamoto et al., 2001; Iwamoto
et al., 2002; Iwamoto et al., 2003; Iwamoto, 2009; Ochala et al., 2011).
For each fiber, both ends were clamped to half-split gold meshes for
electron microscopy (width, 3 mm), which had been glued to precision-
machined ceramic chips (width, 3 mm) designed to fit to a specimen
chamber. The arrays were then transferred to the skinning solution and
stored at 20 °C.
On the day of X-ray recordings, arrays were placed in a plastic dish
containing a pre-activating solution and washed thoroughly to remove
the glycerol. They were then transferred to the specimen chamber,
capable of manual length adjustment and force measurement (force
transducer, AE801; Memscap, Bernin, France), and filled with the pre-
activating solution. Mean sarcomere length was measured and set to
2.70 lm. Subsequently, X-ray diffraction patterns were recorded at
15 °C, first in the pre-activating solution and then in the activating
solution (pCa 4.5) when maximal steady -state isometric force was
reached. It should be mentioned that the activating solution was
supplied to the chamber using a remote-controlled pump.
For each array, approximately 10–20 diffraction patterns were
recorded for each solution at the BL45XU beamline of SPring-8 and
were analyzed as described previously (Iwamoto et al., 2001, 2002,
2003; Iwamoto, 2009). The wavelength was 0.09 nm, and the speci-
men-to-detector distance was 2 m. As a detector, a cooled CCD camera
(C4880, Hamamatsu Photonics; 1000 9 1018 pixels) was used in
combination with an image intensifier (VP5445; Hamamatsu Photonics,
Hamamatsu, Japan). To minimize radiation damage, the exposure time
was kept low (2 s) and the specimen chamber was moved by 100 lm
after each exposure. Moreover, we placed an aluminum plate (thickness
0.35–0.5 mm) upstream of the specimen chamber. The beam flux was
estimated to be between 2.7 9 1011 and 4.0 9 1011 photons s1 after
attenuation, and the beam size at the sample position was 0.2 mm
(vertical) and 0.3 mm (horizontal). Following X-ray recordings, back-
ground scattering was subtracted, and reflection intensities (except for
equatorial reflections) were determined as described elsewhere previ-
ously (Iwamoto et al., 2001, 2002, 2003; Iwamoto, 2009).
Relaxing and activating solutions contained 4 mM Mg-ATP, 1 mM free
Mg2+, 20 mM imidazole, 7 mM EGTA, 14.5 mM creatine phosphate,
324 U mL1 creatine phosphokinase, 1000 U mL1 catalase, and KCl to
adjust the ionic strength to 180 mM and pH to 7.0. Dithiothreitol (DTT)
was also added. The pre-activating solution was identical to the relaxing
solution except that the EGTA concentration was reduced to 0.5 mM.
The concentrations of free Ca2+ were 109.0 M (pCa 9.0, relaxing and
pre-activating solutions) and 104.5 M (pCa 4.5, activating solution).
Post-translational modifications
Cross-sections from the vastus lateralis muscle of both young and old
human subjects were run on 6% SDS-PAGE gels for MyHC isoforms
separations. Gel bands corresponding to MyHC I, IIa, and IIx were
excised. Gel pieces were destained by multiple rinsing with 50:50
ACN:100 mM NH4HCO3 followed by reduction with 15 mM solution of
dithiothreitol in 100 mM NH4HCO3 (30 min at 56 °C) and alkylation with
2.1-fold of iodoacetamide (30 min in the dark at room temperature).
The liquid was removed, and gel pieces were washed with 100% ACN
and then dried at 50 °C. Trypsin solution (25 lg mL1 in 50 mM
NH4HCO3) was added, and the samples were first soaked at 8 °C for
60 min and then digested at 37 °C overnight. After digestion, the
samples were sonicated for 5 min and the liquid was collected and dried
under vacuum.
A 7-tesla LTQ-FT ICR Ultra tandem mass spectrometer (ThermoFisher
ScientificInc. Waltham, MA, USA) modified with a nano electrospray ion
source (Proxeon Biosystems, Roskilde, Denmark) was used for all
analyses. The samples were diluted in water/TFA (1:0.005 v/v), and
peptides were separated by an Agilent 1100 nanoflow system (Agilent
Technologies, Santa Clara, CA, USA) equipped with a homemade 15-cm
fused silica emitter packed with Reprosil-Pur C18-AQ 3 lm resin (Dr.
Maisch GmbH) and coupled online to the mass spectrometer. Peptides
were eluted with a 40-min linear gradient from 2% to 45% acetonitrile
at 200 nL min1. The mass spectrometer was operated in positive ion
mode, and during each run, it automatically switched between a high-
resolution (resolving power 50 000) survey mass spectrum in the FTMS
cell and consecutive low-resolution CID spectra of the five most
abundant ions in the ion trap. The acquired data (.RAW-files) were
converted by in-house written program to Mascot generic format files.
Peptide identification was performed using the Mascot search engine
(version 2.1.3; Matrix Science Ltd, London, UK) by searching the Uniprot-
Swissprot database with set ‘Homo sapiens’ taxonomy. Searches were
performed with trypsin specificity and up to two missed cleavages were
allowed. Mass deviation for precursor ions was set to 0.02 Da. For
fragment ions, the mass deviation was set to 0.7 Da.
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Carbamidomethylation was chosen as a fixed modification, and the
instrument setting was ‘ESI-FTICR’. The peptide/protein identifications
were based on MudPIT scoring. To search all possible post-translational
modifications, the searches were repeated four times for each sample.
The searches were performed with all above mentioned settings and
variable modifications set to: (a) deamidation (N, Q), oxidation (M),
phosphorylation (S, T), phosphorylation (Y), methylation (C-terminus),
and methylation (D, E); (b) deamidation (N, Q), oxidation (M), oxidation
(W), oxidation (H), oxidation (R), oxidation (P), oxidation (Y); (c)
deamidation (N, Q), oxidation (M), oxidation (D), oxidation (F), oxidation
(K), oxidation (N); (d) deamidation (N, Q), oxidation (M), acetylation (K),
acetylation (C-terminus), acetylation (C), acetylation (S), nitration (Y),
nitration (W).
The output Mascot results were exported as XML files, and data with
a peptide scores below 25 were excluded. All remaining peptides we
filtered by exclusion of (a) nonmodified peptides; (b) peptides containing
only oxidation (M) and/or deamidation (N, Q); (c) peptides belonging to
any proteins others than myosin family; (d) same peptides identified
multiple times in the same sample.
MyHC isoforms identification
After motility assay for force and speed measurements, each fiber
segment was placed in sodium dodecyl sulfate (SDS) sample buffer in a
plastic microfuge tube and stored at 80 °C. The MyHC composition of
a muscle fiber was determined by 6% SDS-PAGE. The acrylamide
concentration was 4% (wt/vol) in the stacking gel and 6% in the running
gel, and the gel matrix included 30% glycerol. Sample loads were kept
small (equivalent to ~0.05 mm of fiber segment) to improve the
resolution of the MyHC bands (type I, IIa, and IIx). Electrophoresis was
performed at 120 V for 24 h with a Tris-glycine electrode buffer (pH 8.3)
at 15 °C (SE 600 vertical slab gel unit; Hoefer Scientific Instruments,
Holliston, MA, USA). The gels were silver-stained and subsequently
scanned in a soft laser densitometer (Molecular Dynamics, Sunnyvale,
CA, USA) with a high spatial resolution (50 lm pixel spacing) and 4096
optical density levels (Larsson et al., 1993). The volume integration
function (IMAGEQUANT software version 3.3; Molecular Dynamics) was
used to quantify the relative amount of each MyHC isoform when more
than one isoform was expressed in the fiber segment.
Statistics
The mean, standard deviation (SD), and median values were calculated
according to standard procedures by the software SIGMAPLOT 12.0 (Systat
Software Inc., CA, USA). Student’s t-test was used for comparisons
between two groups after passing the normality test. Two-way ANOVA
was used to test the effect of both age and MyHC isoform. Pearson’s
product moment correlation was used to evaluate linear relations
between the fraction of moving filaments and a-actinin concentration.
Differences were considered statistically significant at P < 0.05.
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